Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-03-20

FDA Approved: BICALUTAMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Bicalutamide from Sun Pharmaceutical Industries, indicating a label update or related change.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bicalutamide (bicalutamide)

Snippet

SUPPL AP for BICALUTAMIDE (BICALUTAMIDE)